Panu E. Kovanen

3.9k total citations
44 papers, 2.3k citations indexed

About

Panu E. Kovanen is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Panu E. Kovanen has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Panu E. Kovanen's work include Cytokine Signaling Pathways and Interactions (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Panu E. Kovanen is often cited by papers focused on Cytokine Signaling Pathways and Interactions (9 papers), Lymphoma Diagnosis and Treatment (8 papers) and Immune Cell Function and Interaction (7 papers). Panu E. Kovanen collaborates with scholars based in Finland, Sweden and United States. Panu E. Kovanen's co-authors include Riku Turkki, Nina Linder, Johan Lundin, Stig Nordling, Clare Verrill, Mikael Lundin, Warren J. Leonard, Caj Haglund, Dmitrii Bychkov and Tuomo Timonen and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Panu E. Kovanen

44 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Panu E. Kovanen Finland 26 755 691 627 422 415 44 2.3k
Bárbara Pesce Chile 17 454 0.6× 527 0.8× 1.2k 1.9× 291 0.7× 192 0.5× 37 2.2k
David Verbel United States 21 327 0.4× 871 1.3× 1.2k 1.9× 289 0.7× 516 1.2× 46 2.9k
Klaus Beiske Norway 35 1.3k 1.8× 1.2k 1.8× 938 1.5× 62 0.1× 352 0.8× 119 4.1k
In Hye Song South Korea 26 716 0.9× 988 1.4× 347 0.6× 126 0.3× 252 0.6× 82 2.0k
Teijo Pellinen Finland 31 595 0.8× 1.1k 1.5× 1.5k 2.4× 73 0.2× 164 0.4× 85 3.4k
Christian A. Kunder United States 24 266 0.4× 364 0.5× 481 0.8× 155 0.4× 346 0.8× 80 1.8k
Karin A. Oien United Kingdom 31 258 0.3× 2.1k 3.0× 1.1k 1.8× 205 0.5× 239 0.6× 64 3.6k
Lisa M. Maier United States 20 1.1k 1.5× 237 0.3× 668 1.1× 206 0.5× 68 0.2× 21 2.6k
Harri Sihto Finland 33 181 0.2× 1.8k 2.5× 1.0k 1.6× 93 0.2× 217 0.5× 80 3.8k
Robert J. Marinelli United States 17 333 0.4× 673 1.0× 477 0.8× 369 0.9× 276 0.7× 19 2.1k

Countries citing papers authored by Panu E. Kovanen

Since Specialization
Citations

This map shows the geographic impact of Panu E. Kovanen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Panu E. Kovanen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Panu E. Kovanen more than expected).

Fields of papers citing papers by Panu E. Kovanen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Panu E. Kovanen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Panu E. Kovanen. The network helps show where Panu E. Kovanen may publish in the future.

Co-authorship network of co-authors of Panu E. Kovanen

This figure shows the co-authorship network connecting the top 25 collaborators of Panu E. Kovanen. A scholar is included among the top collaborators of Panu E. Kovanen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Panu E. Kovanen. Panu E. Kovanen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leivonen, Suvi‐Katri, Matias Autio, Samuli Vaittinen, et al.. (2023). Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas. Haematologica. 108(11). 3044–3057. 2 indexed citations
2.
Tervonen, Topi A., Johanna I. Englund, Katja Maria Närhi, et al.. (2021). Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin. Cancer Research. 81(6). 1513–1527. 12 indexed citations
3.
Brück, Oscar, Helena Hohtari, Aleksandr Ianevski, et al.. (2021). Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS. Blood Cancer Discovery. 2(3). 238–249. 36 indexed citations
4.
Hohtari, Helena, Oscar Brück, Sami Blom, et al.. (2019). Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL. Leukemia. 33(7). 1570–1582. 47 indexed citations
5.
Savola, Paula, Timi Martelius, Matti Kankainen, et al.. (2019). Somatic mutations and T-cell clonality in patients with immunodeficiency. Haematologica. 105(12). 2757–2768. 19 indexed citations
6.
Brück, Oscar, Sami Blom, Olli Dufva, et al.. (2018). Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML. Leukemia. 32(7). 1643–1656. 69 indexed citations
7.
Hekim, Can, Mette Ilander, Jun Yan, et al.. (2017). Dasatinib Changes Immune Cell Profiles Concomitant with Reduced Tumor Growth in Several Murine Solid Tumor Models. Cancer Immunology Research. 5(2). 157–169. 37 indexed citations
8.
Mäkitie, Riikka E., et al.. (2017). Defective WNT signaling associates with bone marrow fibrosis—a cross-sectional cohort study in a family with WNT1 osteoporosis. Osteoporosis International. 29(2). 479–487. 10 indexed citations
9.
Savola, Paula, Oscar Brück, Thomas L. Olson, et al.. (2017). Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia. Haematologica. 103(2). 304–312. 51 indexed citations
10.
Turkki, Riku, Nina Linder, Panu E. Kovanen, Teijo Pellinen, & Johan Lundin. (2016). Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples. Journal of Pathology Informatics. 7(1). 38–38. 71 indexed citations
11.
Tervonen, Topi A., Johanna I. Englund, Harri Sihto, et al.. (2015). Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion. Oncogene. 35(14). 1832–1846. 32 indexed citations
12.
Tervonen, Topi A., Johanna I. Partanen, Sirkku T. Saarikoski, et al.. (2011). Faulty Epithelial Polarity Genes and Cancer. Advances in cancer research. 111. 97–161. 19 indexed citations
13.
Mustjoki, Satu, Marja Ekblom, T. Petteri Arstila, et al.. (2009). Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia. 23(8). 1398–1405. 229 indexed citations
14.
Kovanen, Panu E., Jérôme Bernard, Amin Al-Shami, et al.. (2008). T-cell Development and Function Are Modulated by Dual Specificity Phosphatase DUSP5. Journal of Biological Chemistry. 283(25). 17362–17369. 49 indexed citations
15.
Kovanen, Panu E., Lynn Young, Amin Al-Shami, et al.. (2005). Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. International Immunology. 17(8). 1009–1021. 45 indexed citations
16.
Kovanen, Panu E., Andreas Rosenwald, Elaine M. Hurt, et al.. (2003). Analysis of γc-Family Cytokine Target Genes. Journal of Biological Chemistry. 278(7). 5205–5213. 79 indexed citations
17.
Kelly, John A., Rosanne Spolski, Panu E. Kovanen, et al.. (2003). Stat5 Synergizes with T Cell Receptor/Antigen Stimulation in the Development of Lymphoblastic Lymphoma. The Journal of Experimental Medicine. 198(1). 79–89. 61 indexed citations
18.
Silvennoinen, Olli, Pipsa Saharinen, Kirsi Paukku, Kati Takaluoma, & Panu E. Kovanen. (1997). Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors. Apmis. 105(7-12). 497–509. 26 indexed citations
19.
20.
Kovanen, Panu E., Kaarle Franssila, Païvi Peltomäki, & Sakari Knuutila. (1990). Effect of a low-molecular-weight B cell growth factor on the proliferation of normal and neoplastic lymphocytes in lymphomas. Cancer Genetics and Cytogenetics. 48(1). 109–118. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bárbara Pesce Breakdown of academic impact, for papers by David Verbel Breakdown of academic impact, for papers by Klaus Beiske Breakdown of academic impact, for papers by In Hye Song Breakdown of academic impact, for papers by Teijo Pellinen Breakdown of academic impact, for papers by Christian A. Kunder Breakdown of academic impact, for papers by Karin A. Oien Breakdown of academic impact, for papers by Lisa M. Maier Breakdown of academic impact, for papers by Harri Sihto Breakdown of academic impact, for papers by Robert J. Marinelli
Rankless by CCL
2026